Agilent Technologies Inc (NYSE:A), a provider of analytical and clinical laboratory technologies, on Friday launched the Agilent S540MD Slide Scanner System in the United States following FDA clearance, expanding its digital pathology portfolio for clinical laboratories.
The whole slide imaging (WSI) system is designed to support high-throughput pathology workflows amid growing sample volumes and demand for diagnostic efficiency. It can hold up to 540 slides, supports continuous loading and standard rack compatibility, and features automated scanning modes and advanced tissue detection.
The S540MD is the Agilent-branded version of the Hamamatsu NanoZoomer S540MD Slide scanner system. The US launch follows its January 2026 introduction in selected European markets.
The scanner is now available in the United States and Germany, the United Kingdom, France, Italy, Spain, Switzerland, Austria, Belgium, the Netherlands, Luxembourg, Denmark, Sweden, Norway and Finland.
Vir Biotechnology's VIR-5500 receives FDA Fast Track designation for prostate cancer
FDA accepts Bayer's application for KERENDIA in chronic kidney disease without diabetes
Okami Medical receives FDA approval for expanded indication of LOBO Vascular Occluder
Kedrion to be honoured at Premier's Supplier Innovation Celebration
Zydus and MSN announce US launch of generic Adempas (Riociguat Tablets)
FDA approves second Reykjavik manufacturing suite for AVT02
Ractigen Therapeutics reports positive first-in-human data for RAG-18 in Duchenne muscular dystrophy
AnnJi Pharmaceutical's AJ201 advances into pivotal Phase 3 trial for SBMA